This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Basu, H. S. Articles by Marton, L. J. Search for Related Content PubMed PubMed Citation Articles by Basu, H. S. Articles by Marton, L. J.

Interaction of a Polyamine Analogue, 1,19-bis-(Ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4), with DNA and Effect on Growth, Survival, and Polyamine Levels in Seven Human Brain Tumor Cell Lines¹

Brain Tumor Research Center of the Department of Neurological Surgery [H. S. B., M. P., B. G. F., D. F. D., L. J. M.], Department of Laboratory Medicine [B. G. F., L. J. M.], Department of Pediatrics [B. G. F.], and Department of Radiation Oncology [D. F. D.], School of Medicine, University of California, San Francisco, California 94143, and Faculty of Pharmaceutical Sciences, Josai University, Keyakidai, Sakado, Saitama, Japan [A. S., K. S.]

Computer graphics modeling and physicochemical studies of spermine-DNA interactions, as well as experiments in cell culture, indicate that a polyamine analogue with strong affinity for nucleic acids but poor ability to condense and aggregate DNA in vitro should act as an antiproliferative agent if it can enter cells. On the basis of our studies of polyamine-DNA interactions, we designed a pentamine, 1,19-bis(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4), that had these characteristics. Measurement of melting temperature and ultraviolet light scattering studies show that the affinity of this analogue for calf-thymus DNA is about 4 times higher than that of spermine, whereas its ability to aggregate DNA is slightly poorer than that of spermine.

Studies in U-87 MG, U-251 MG, SF-126, SF-188, SF-763, SF-767, and DAOY human brain tumor cells in tissue culture showed that treatment for more than 96 h with concentrations of 5 µM BE-4-4-4-4 or greater inhibited growth; decreased levels of putrescine, spermidine, and spermine; and decreased colony-forming ability in all cell lines. The cytotoxicity of the analogue varied among cell lines; DAOY and SF-767 were the most sensitive and the most resistant lines, respectively. In SF-763 cells, growth inhibition by BE-4-4-4-4 could be partially reversed by the addition of putrescine, spermidine, or spermine 1 day after BE-4-4-4-4 addition, but in U-251 MG cells, growth inhibition was reversed only by spermine and not by other polyamines. When any of the naturally occurring polyamines was added simultaneously with BE-4-4-4-4, growth inhibition was completely blocked. The data suggest that a threshold intracellular concentration of BE-4-4-4-4 is needed to manifest the growth-inhibitory and cytotoxic effects. In most cell lines, once that threshold level is reached, the growth-inhibitory and cytotoxic properties of the analogue are manifest irrespective of cellular polyamine levels. Further increases in the BE-4-4-4-4 concentration or incubation time reduce the intracellular polyamine levels but do not significantly increase growth inhibition. In U-87 MG and DAOY cells, however, prolonged incubation with higher concentrations of BE-4-4-4-4 causes additional growth inhibition along with depletion of intracellular polyamines. Thus, it appears that polyamine analogues having higher affinity for DNA than natural polyamines can inhibit cell growth even in the presence of natural polyamines, if they are taken up by cells to a sufficient degree to compete with and displace natural polyamines from their binding sites on DNA.

¹ Supported by Grants CA 49409 and CA 13525 from the NIH.

² To whom requests for reprints should be addressed, at the Department of Neurological Surgery, c/o The Editorial Office, 1360 Ninth Avenue, Suite 210, San Francisco, CA 94122.

Received 2/ 7/92. Accepted 6/28/93.

This article has been cited by other articles:

				C. J. Bacchi, L. M. Weiss, S. Lane, B. Frydman, A. Valasinas, V. Reddy, J. S. Sun, L. J. Marton, I. A. Khan, M. Moretto, et al. Novel Synthetic Polyamines Are Effective in the Treatment of Experimental Microsporidiosis, an Opportunistic AIDS-Associated Infection Antimicrob. Agents Chemother., January 1, 2002; 46(1): 55 - 61. [Abstract] [Full Text] [PDF]

				S. P. Harris, J. R. Patel, L. J. Marton, and R. L. Moss Polyamines decrease Ca2+ sensitivity of tension and increase rates of activation in skinned cardiac myocytes Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1383 - H1391. [Abstract] [Full Text] [PDF]

				L. Maletínská, E. A. Blakely, K. A. Bjornstad, D. F. Deen, L. J. Knoff, and T. M. Forte Human Glioblastoma Cell Lines: Levels of Low-Density Lipoprotein Receptor and Low-Density Lipoprotein Receptor-related Protein Cancer Res., April 1, 2000; 60(8): 2300 - 2303. [Abstract] [Full Text]

				D. L. Kramer, S. Vujcic, P. Diegelman, J. Alderfer, J. T. Miller, J. D. Black, R. J. Bergeron, and C. W. Porter Polyamine Analogue Induction of the p53-p21WAF1/CIP1-Rb Pathway and G1 Arrest in Human Melanoma Cells Cancer Res., March 1, 1999; 59(6): 1278 - 1286. [Abstract] [Full Text] [PDF]

				D. E. McCloskey and A. E. Pegg Altered Spermidine/Spermine N1-Acetyltransferase Activity as a Mechanism of Cellular Resistance to Bis(ethyl)polyamine Analogues J. Biol. Chem., September 8, 2000; 275(37): 28708 - 28714. [Abstract] [Full Text] [PDF]